Pilsicainide

This classification denotes an antiarrhythmic agent with the molecular formula C17H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) AV0X7V6CSE, chemically known as 1h-pyrrolizine-7a(5h)-acetamide, n-(2,6-dimethylphenyl)tetrahydro- but more generally known as pilsicainide, which bears US NIH Compound Identifier 4820. European Medicines Agency schedules Pilsicainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09834MIG. The term PILSICAINIDE is an International Non-Proprietary Name. PILSICAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pilsicainide under HS 29339990 and SITC 51577. As of Q4 2014, PILSICAINIDE remains US FDA's Preferred Term for this commodity. Pilsicainide bears US NLM identifiers UMLS ID C0164155 and NCI Concept Code C72582. SMILES: O=C(NC1C(CCCC1C)C)CC12N(CCC1)CCC2.